FEATURED POST
Simplify CRO Collaboration & Data Sharing for Drug Discovery Teams with Signals Synergy
April 2, 2024 Read Blog
WRITTEN BY:
Chris Stumpf
Senior Principal Marketing Professional, Revvity Signals Software, Inc.
Blogs & Articles
Featured Blogs
Filter
November 12, 2024 Zev Wisotsky, Ph.D.
The Evolving Landscape of PROTAC® Technology: Implications for Small Molecule and Multimodal Drug Discovery
PROTAC technology and TPD research present many opportunities in drug discovery. Learn how Signals Research Suite provides a comprehensive R&D workflow.
October 29, 2024 Jun Liu
Unlocking Insights Through Data: Digital Transformation in Formulation Science
October 15, 2024 Zev Wisotsky, Ph.D.
Signals Research Suite Unlocks RNA's Potential | Revvity Signals Software
Signals Research Suite has RNA specific tools for leading biopharmaceutical companies to make data-driven decisions. Learn how we meet chemists and RNA biologists needs.
R&D Reimagined: AI’s Role in Turning ‘What Ifs’ into ‘Why Not?’ in Pharma & Biotech
Revvity Signals offers AI solutions for R&D scientists and researchers. Learn how Signals Research Suite supports AI capabilities driving modern scientific discovery.
September 17, 2024 Zev Wisotsky, Ph.D.
AI-Powered Drug Discovery Possibilities | Revvity Signals Software
Revvity Signals helps take advantage of AI-ready data within antibody drug discovery. Learn how Signals Research Suite can help accelerate scientific.
September 3, 2024 Chris Stumpf
The Impact of Software Platforms on CRO and Biopharma Partnerships | Revvity Signals Software
Signals Synergy enhances collaboration and information between CROs and sponsors. Learn how Signals Synergy improves communication and project management with CROs.
August 20, 2024 Pierre Morieux, Ph.D.
The Future of Chemical Drawing | Revvity Signals Software
ChemDraw+ is not just an upgrade; it’s a game-changer, designed for today’s evolving needs of chemists. Learn what ChemDraw+ offers and how to request a free trial.
